These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15189938)

  • 1. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
    Collard HR; Ryu JH; Douglas WW; Schwarz MI; Curran-Everett D; King TE; Brown KK
    Chest; 2004 Jun; 125(6):2169-74. PubMed ID: 15189938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: a single center experience and literature review.
    Novelli L; Ruggiero R; De Giacomi F; Biffi A; Faverio P; Bilucaglia L; Gamberini S; Messinesi G; Pesci A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):385-391. PubMed ID: 28079851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
    Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.
    Pereira CA; Malheiros T; Coletta EM; Ferreira RG; Rubin AS; Otta JS; Rocha NS
    Respir Med; 2006 Feb; 100(2):340-7. PubMed ID: 16002271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.
    Zisman DA; Lynch JP; Toews GB; Kazerooni EA; Flint A; Martinez FJ
    Chest; 2000 Jun; 117(6):1619-26. PubMed ID: 10858393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of pulmonary fibrosis].
    Cottin V
    Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic pulmonary fibrosis; description of a Dutch cohort].
    Barlo NP; van Moorsel CH; van den Bosch JM; van de Graaf EA; Kwakkel-van Erp JM; Grutters JC
    Ned Tijdschr Geneeskd; 2009; 153():B425. PubMed ID: 19785823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
    Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung transplantation for idiopathic pulmonary fibrosis.
    Mason DP; Brizzio ME; Alster JM; McNeill AM; Murthy SC; Budev MM; Mehta AC; Minai OA; Pettersson GB; Blackstone EH
    Ann Thorac Surg; 2007 Oct; 84(4):1121-8. PubMed ID: 17888957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in Japan.
    Oda K; Yatera K; Fujino Y; Ishimoto H; Nakao H; Hanaka T; Ogoshi T; Kido T; Fushimi K; Matsuda S; Mukae H
    BMC Pulm Med; 2016 Jun; 16(1):91. PubMed ID: 27278093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies.
    Dayton CS; Schwartz DA; Helmers RA; Pueringer RJ; Gilbert SR; Merchant RK; Hunninghake GW
    Chest; 1993 Jan; 103(1):69-73. PubMed ID: 8417939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis.
    Alhamad EH; Masood M; Shaik SA; Arafah M
    Clin Respir J; 2008 Oct; 2(4):220-6. PubMed ID: 20298338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.
    van Oortegem K; Wallaert B; Marquette CH; Ramon P; Perez T; Lafitte JJ; Tonnel AB
    Eur Respir J; 1994 Nov; 7(11):1950-7. PubMed ID: 7875264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis.
    Hanson D; Winterbauer RH; Kirtland SH; Wu R
    Chest; 1995 Aug; 108(2):305-10. PubMed ID: 7634857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose corticosteroid treatment in septic shock: a propensity-matching study.
    Funk D; Doucette S; Pisipati A; Dodek P; Marshall JC; Kumar A;
    Crit Care Med; 2014 Nov; 42(11):2333-41. PubMed ID: 25072758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival.
    Flaherty KR; Toews GB; Lynch JP; Kazerooni EA; Gross BH; Strawderman RL; Hariharan K; Flint A; Martinez FJ
    Am J Med; 2001 Mar; 110(4):278-82. PubMed ID: 11239846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis.
    Baughman RP; Lower EE
    Chest; 1992 Oct; 102(4):1090-4. PubMed ID: 1395749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory agents for idiopathic pulmonary fibrosis.
    Davies HR; Richeldi L; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic pulmonary fibrosis: predicting response to therapy and survival.
    Gay SE; Kazerooni EA; Toews GB; Lynch JP; Gross BH; Cascade PN; Spizarny DL; Flint A; Schork MA; Whyte RI; Popovich J; Hyzy R; Martinez FJ
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1063-72. PubMed ID: 9563720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.